Table of Contents
Licensing
| Repertoire Signs US$765 M Partnership with Genentech to Advance T Cell Therapies for Autoimmune Diseases | Abstract pdf html |
| Hitesh Udar & Lucy Haggerty |
Mergers & Acquisitions
| Merck KGaA to Acquire Rare Tumour Specialist SpringWorks Therapeutics for US$3.9 B | Abstract pdf html |
| Lucy Haggerty |
| Novartis to Acquire Regulus Therapeutics and Farabursen for US$1.7 B | Abstract pdf html |
| Naini Anand |
This work is licensed under a Creative Commons Attribution 3.0 License.